[Form 3] Cyclacel Pharmaceuticals, Inc. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

FITTERS Diversified Berhad reported initial beneficial ownership of 699,158 shares of Bio Green Med Solution, Inc. (BGMS) common stock on a Form 3 filed after an exchange agreement dated May 6, 2025 that closed on September 12, 2025. The filing lists FITTERS as a director of the issuer and states the shares are held directly. The Form 3 is signed by Datuk Tan Chor How Christopher on September 16, 2025. No derivative securities, option grants, or additional terms are disclosed in the filing.

Positive

• Initial disclosure of a director-related stake provides transparency to investors
• 699,158 shares were issued pursuant to a completed exchange agreement, clearly dated

Negative

• None.

Insights

Securities Analyst

TL;DR: Director-level entity received 699,158 shares via a completed exchange agreement; disclosure is routine but relevant for ownership tracking.

The Form 3 documents an initial direct stake by FITTERS Diversified Berhad in BGMS following an exchange agreement that closed on September 12, 2025. From a securities disclosure perspective this is a standard Section 16 filing that informs investors of a director-related ownership position. The filing contains no derivatives, vesting schedules, or additional economic terms, limiting assessment to share count and timing. Without company market-cap or outstanding share data in this filing, the materiality of 699,158 shares cannot be gauged here.

Corporate Governance Expert

TL;DR: The disclosure fulfills initial beneficial ownership requirements; it signals director-level alignment but lacks context on voting power.

The report complies with Section 16 initial reporting norms by identifying the reporting entity, relationship to the issuer (director), exact share amount, and the transaction date. It improves transparency about insider holdings but omits information needed to assess control implications, such as total outstanding shares or whether shares carry special voting rights. No amendments or complex instruments are reported.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

FITTERS Diversified Berhad

(Last) (First) (Middle)

NO. 1, JALAN TEMBAGA SD 5/2

BANDAR SRI DAMANSARA

(Street)

KUALA LUMPUR N8 52200

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/12/2025

3. Issuer Name and Ticker or Trading Symbol
Bio Green Med Solution, Inc. [ BGMS ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	699,158(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. In connection with an exchange agreement dated May 6, 2025, as amended, which closed on September 12, 2025, FITTERS Diversified Berhad was issued 699,158 shares of the Company's common stock.

	/s/ Datuk Tan Chor How Christopher	09/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did FITTERS Diversified Berhad report on Form 3 for BGMS?

The filer reported beneficial ownership of 699,158 shares of Bio Green Med Solution, Inc. (BGMS) common stock held directly following an exchange agreement.

When did the exchange agreement that led to the share issuance close?

The exchange agreement closed on September 12, 2025, and the Form 3 lists that date as the event requiring the statement.

What relationship does the reporting person have to BGMS?

The filing indicates FITTERS Diversified Berhad is a director of the issuer.

Are any derivative securities or options reported on this Form 3?

No. The filing shows only non-derivative common stock ownership; no derivative securities are listed.

Who signed the Form 3 and when was it signed?

The Form 3 was signed by Datuk Tan Chor How Christopher on September 16, 2025.